Innovation Pharmaceuticals Inc (IPIX)

[djs7]

Friend, you act as if you knew everything since cohort 2. I'm glad you believe in God, but sometimes your arrogance gets the best of you. This phase 1 was intended to test for safety and hopefully determine some kind of efficiency, but only for now as a once a week dose for patients who have drug resistance to everything else and at stage 4 who are barely given the next day to live. Its wonderful of Cellceutix to offer this option at such a dire time for people looking for hope like the one patient who suffered a DLT at 350 but so desperately wanted to continue and will at 215. Phase 2 will look at multi-dosing per week and a mix of different cancer stage patients to see what situations the highest P21 efficieny can be achieved. Until then, perhaps you should stay somewhat guarded and keep your mouth shut to 100% head nodding of your opinion. Need I say more friend??